Scientists debunked a common myth. It's about hormone replacement therapy

Recent research involving over 52,000 women aged 45-59 indicates that hormone replacement therapy (HRT) does not increase the risk of heart attacks, strokes, or blood clots. This study contrasts with older research from the 1990s and 2000s that linked HRT to cardiovascular issues, primarily due to higher doses and later initiation of therapy. The findings, presented at the American Heart Association Scientific Sessions 2026, suggest that HRT can be safely administered to healthy women within ten years of menopause. The study monitored participants for an average of 12 years, revealing similar rates of cardiovascular problems and mortality between those on HRT and those not. Additionally, a separate study confirmed no increased cancer risk associated with HRT, leading to the FDA removing previous warnings about HRT products.